Investigación / Grupos de investigación

Publicaciones (167)

  • Angulo, JC; Arance, I; Ojea, A; Carballo, M; Rodriguez, A; Pereira, J; Rebassa, M; Teyrouz, A; Escribano, G; Teba, F; Madurga, B; Martins, FE; Cruz, F.

    Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study

    WORLD JOURNAL OF UROLOGY. 2019; 37(10): 2189-2197 Nº de citas: 13 [doi:10.1007/s00345-019-02639-4]

  • Pujol, LP; Garcia, EL; Velasco, JC; Garcia, FJG; Rascon, JJ; Fernandez, CH.

    Prostate cryotherapy: General principles

    ARCHIVOS ESPANOLES DE UROLOGIA. 2019; 72(8): 816-824

  • Cano-Velasco, J; Herranz-Amo, F; Peligros-Gomez, I; Barbas-Bernardos, G; Sola-Vendrell, E; Hernandez-Fernandez, C.

    Mucin-producing urothelial type prostatic adenocarcinoma with signet ring cells and increased Ca 19.9 and CEA. Case report and literature review

    ARCHIVOS ESPANOLES DE UROLOGIA. 2019; 72(7): 647-652 Nº de citas: 2

  • Subira-Rios, D; Herranz-Amo, F; Moralejo-Garate, M; Cano-Velasco, J; Renedo-Villar, T; Barbas-Bernardos, G; Bueno-Chomon, G; Rodriguez-Fernandez, E; Hernandez-Fernandez, C.

    Post-surgical complications in patients with bladder cancer treated with cystectomy: Differences between open and laparoscopic approach

    Actas Urologicas Espanolas. 2019; 43(6): 305-313 Nº de citas: 8 [doi:10.1016/j.acuro.2018.12.001]

  • Subira-Rios, D; Herranz-Amo, F; Renedo-Villar, T; Moralejo-Garate, M; del Pozo-Jimenez, G; Bueno-Chomon, G; Rodriguez-Fernandez, E; Moncada-Iribarren, I; Hernandez-Fernandez, C.

    Influence of laparoscopic access in cancer-specific mortality of patients with pTa-2pN0R0 bladder cancer treated with radical cistectomy

    Actas Urologicas Espanolas. 2019; 43(5): 241-247 [doi:10.1016/j.acuro.2019.01.001]

  • Bernardos, GB; Amo, FH; Campos, ED; Cardo, AL; Arriero, AH; Gil, MJC; Velasco, JC; Rascon, JJ; de Castro, JM; Fernandez, CH.

    Comparison of classical transrectal prostate biopsy versus cognitive registration in rebiopsy

    Actas Urologicas Espanolas. 2019; 43(5): 228-233 [doi:10.1016/j.acuro.2018.06.010]

  • Hevia, V; Hassan Zakri R; Fraser Taylor C; Bruins, HM; Boissier, R; Lledo, E; Regele, H; Budde, K; Figueiredo, A; Breda, A; Yuan, CY; Olsburgh, J.

    Effectiveness and Harms of Using Kidneys with Small Renal Tumors from Deceased or Living Donors as a Source of Renal Transplantation: A Systematic Review

    European Urology Focus. 2019; 5(3): 508-517 Nº de citas: 13 [doi:10.1016/j.euf.2018.01.018]

  • Cano-Velasco, J; Herranz-Amo, F; Barbas-Bernardos, G; Polanco-Pujol, L; Verdu-Tartajo, F; Lledo-Garcia, E; Hernandez-Fernandez, C.

    Oncological control in high-risk prostate cancer after radical prostatectomy and salvage radiotherapy compared to radiotherapy plus primary hormone therapy

    Actas Urologicas Espanolas. 2019; 43(4): 190-197 Nº de citas: 2 [doi:10.1016/j.acuro.2018.07.007]

  • Cano-Velasco, J; Herranz-Amo, F; Barbas-Bernardos, G; Polanco-Pujol, L; Hernandez-Cavieres, J; Lledo-Garcia, E; Hernandez-Fernandez, C.

    Differences in overall survival and cancer-specific survival in high-risk prostate cancer patients according to the primary treatment

    Actas Urologicas Espanolas. 2019; 43(2): 91-98 Nº de citas: 5 [doi:10.1016/j.acuro.2018.06.006]

  • Barbas Bernardos G; Herranz Amo F; Cano Velasco J; Cancho Gil MJ; Mayor de Castro J; Aragon Chamizo J; Polanco Pujol L; Hernandez Fernandez C.

    Influence of venous tumour extension on local and remote recurrence of stage pT3a pN0 cM0 kidney tumours

    Actas Urologicas Espanolas. 2019; 43(2): 77-83 Nº de citas: 3 [doi:10.1016/j.acuro.2018.06.007]

  • Subira-Rios, D; Herranz-Amo, F; Moralejo-Garate, M; Cano-Velasco, J; Renedo-Villar, T; Barbas-Bernardos, G; Bueno-Chomon, G; Rodriguez-Fernandez, E; Hernandez-Fernandez, C.

    Influence of the laparoscopic approach on cancer-specific mortality of patients with stage pt3-4 bladder cancer treated with cystectomy

    Actas Urologicas Espanolas. 2019; 43(2): 71-76 Nº de citas: 1 [doi:10.1016/j.acuro.2018.06.009]

  • Cano-Velasco, J; Herranz-Amo, F; Barbas-Bernardos, G; Polanco-Pujol, L; Lledo-Garcia, E; Hernandez-Fernandez, C.

    Incidence of second tumours in high risk prostate cancer patients according to the primary treatment applied

    Actas Urologicas Espanolas. 2019; 43(1): 18-25 Nº de citas: 4 [doi:10.1016/j.acuro.2018.07.002]

  • Bernardos, GB; Amo, FH; Campos, ED; Cardo, AL; Arriero, AH; Velasco, JC; Gil, MJC; Rascon, JJ; de Castro, JM; Fernandez, CH.

    Effectiveness of the "cognitive" biopsy in the diagnosis of prostate cancer in patients with a previous negative biopsy

    Actas Urologicas Espanolas. 2019; 43(1): 12-17 [doi:10.1016/j.acuro.2018.06.008]

  • Gonzalez, J; Angulo-Morales, FJ; Lledo-Garcia, E.

    Vascular Injury During Urologic Surgery: Somebody Call My Mother

    Current Urology Reports. 2019; 20(1): Nº de citas: 6 [doi:10.1007/s11934-019-0869-5]

  • Cano-Velasco, J; Herranz-Amo, F; Gonzalez-Leyte, M; Barbas-Bernardos, G; Escudero, RM; Pujol, LP; Hernandez-Fernandez, C.

    Intense urethrorrhagia after retropubic radical prostatectomy with selective embolization of the internal pudendal artery

    ARCHIVOS ESPANOLES DE UROLOGIA. 2018; 71(10): 856-859

  • Angulo, JC; Fonseca, J; Esquinas, C; Ojea, A; Rodriguez, A; Rabassa, M; Teba, F; Escribano, G; Cruz, F.

    Adjustable transobturator male system (ATOMS (R)) as treatment of stress urinary incontinence secondary to transurethral resection of the prostate

    Actas Urologicas Espanolas. 2018; 42(9): 567-573 Nº de citas: 5 [doi:10.1016/j.acuroe.2018.09.002]

  • Cano-Velasco, J; Herranz-Amo, F; Barbas-Bernardos, G; Mayor-de Castro, J; Aragon-Chamizo, J; Arnal-Chacon, G; Garcia, EL; Hernandez-Fernandez, C.

    Postsurgical complications in patients with renal tumours with venous thrombosis treated with surgery

    Actas Urologicas Espanolas. 2018; 42(8): 531-537 Nº de citas: 1 [doi:10.1016/j.acuro.2018.02.006]

  • Font, P; Subira, D; Matarraz, S; Benavente, C; Cedena, MT; Morado, M; Corral, AP; Bellon, JM; Diez-Martin, JL.

    Multicenter comparison of CD34+myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

    CYTOMETRY PART B-CLINICAL CYTOMETRY. 2018; 94(3): 527-535 Nº de citas: 8 [doi:10.1002/cyto.b.21538]